Literature DB >> 11817214

Molecular pathways of anxiety revealed by knockout mice.

S J Wood1, M Toth.   

Abstract

Anxiety is a normal reaction to threatening situations, and serves a physiological protective function. Pathological anxiety is characterized by a bias to interpret ambiguous situations as threatening, by avoidance of situations that are perceived to be harmful, and/or by exaggerated reactions to threat. Although much evidence indicates the involvement of the gamma-aminobutyric acid, serotonin, norepinephrine, dopamine, and neuropeptide transmitter systems in the pathophysiology of anxiety, little is known about how anxiety develops and what genetic/environmental factors underlie susceptibility to anxiety. Recently, inactivation of several genes, associated with either chemical communication between neurons or signaling within neurons, has been shown to give rise to anxiety-related behavior in knockout mice. Apart from confirming the involvement of serotonin, gamma-aminobutyric acid, and corticotrophin-releasing hormone as major mediators of anxiety and stress related behaviors, two novel groups of anxiety-relevant molecules have been revealed. The first group consists of neurotrophic-type molecules, such as interferon gamma, neural cell adhesion molecule, and midkine, which play important roles in neuronal development and cell-to-cell communication. The second group comprises regulators of intracellular signaling and gene expression, which emphasizes the importance of gene regulation in anxiety-related behaviors. Defects in these molecules are likely to contribute to the abnormal development and/or function of neuronal networks, which leads to the manifestation of anxiety disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11817214     DOI: 10.1385/MN:23:2-3:101

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  123 in total

1.  Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour.

Authors:  E Nakamura; K Kadomatsu; S Yuasa; H Muramatsu; T Mamiya; T Nabeshima; Q W Fan; K Ishiguro; T Igakura; S Matsubara; T Kaname; M Horiba; H Saito; T Muramatsu
Journal:  Genes Cells       Date:  1998-12       Impact factor: 1.891

Review 2.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function.

Authors:  A P Braun; H Schulman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

3.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

4.  D3 dopamine receptor-deficient mouse: evidence for reduced anxiety.

Authors:  H Steiner; S Fuchs; D Accili
Journal:  Physiol Behav       Date:  1997-12-31

5.  Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins.

Authors:  C Vaillend; A Ungerer
Journal:  Neuromuscul Disord       Date:  1999-07       Impact factor: 4.296

Review 6.  Understanding the molecular basis of fragile X syndrome.

Authors:  P Jin; S T Warren
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

7.  Increased fearfulness of Fyn tyrosine kinase deficient mice.

Authors:  T Miyakawa; T Yagi; S Watanabe; H Niki
Journal:  Brain Res Mol Brain Res       Date:  1994-11

8.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 9.  Transcription factors responsive to cAMP.

Authors:  P Sassone-Corsi
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

10.  Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.

Authors:  G W Smith; J M Aubry; F Dellu; A Contarino; L M Bilezikjian; L H Gold; R Chen; Y Marchuk; C Hauser; C A Bentley; P E Sawchenko; G F Koob; W Vale; K F Lee
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

View more
  13 in total

1.  Anxiety-like behavior and other consequences of early life stress in mice with increased protein kinase A activity.

Authors:  Maddalena Ugolini; Margaret F Keil; Enrica Paradiso; John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2018-04-03       Impact factor: 3.332

Review 2.  Genetic and environmental factors interact to influence anxiety.

Authors:  Cornelius Gross; René Hen
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Anxiety phenotype in mice that overexpress protein kinase A.

Authors:  Margaret F Keil; George Briassoulis; Nirmal Gokarn; Maria Nesterova; T John Wu; Constantine A Stratakis
Journal:  Psychoneuroendocrinology       Date:  2011-10-22       Impact factor: 4.905

4.  Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors.

Authors:  Sarah J Bailey; Miklos Toth
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

5.  Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.

Authors:  George Briassoulis; Margaret F Keil; Bilal Naved; Sophie Liu; Matthew F Starost; Maria Nesterova; Nirmal Gokarn; Anna Batistatos; T John Wu; Constantine A Stratakis
Journal:  Behav Brain Res       Date:  2016-03-16       Impact factor: 3.332

6.  Genetic deletion of Lsamp causes exaggerated behavioral activation in novel environments.

Authors:  Elizabeth Haldeman Catania; Aurea Pimenta; Pat Levitt
Journal:  Behav Brain Res       Date:  2007-12-07       Impact factor: 3.332

7.  Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Marta G Vucković; Ruth I Wood; Daniel P Holschneider; Avery Abernathy; Daniel M Togasaki; Alexandra Smith; Giselle M Petzinger; Michael W Jakowec
Journal:  Neurobiol Dis       Date:  2008-08-05       Impact factor: 5.996

8.  A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.

Authors:  M Jain; J I Vélez; M T Acosta; L G Palacio; J Balog; E Roessler; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; F X Castellanos; J E Bailey-Wilson; M Arcos-Burgos; M Muenke
Journal:  Mol Psychiatry       Date:  2011-05-24       Impact factor: 15.992

9.  Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment.

Authors:  J-E Oh; N Chambwe; S Klein; J Gal; S Andrews; G Gleason; R Shaknovich; A Melnick; F Campagne; M Toth
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

10.  The first mecp2-null zebrafish model shows altered motor behaviors.

Authors:  Thomas Pietri; Angel-Carlos Roman; Nicolas Guyon; Sebastián A Romano; Philip Washbourne; Cecilia B Moens; Gonzalo G de Polavieja; Germán Sumbre
Journal:  Front Neural Circuits       Date:  2013-07-16       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.